Mechanisms of p53-mediated apoptosis

Cellular and Molecular Life Sciences

Volumn 55, Issue 1, 1999, Pages 28-37

  Bates, S ^a   Vousden, K H ^a  

^a Ctr Cancer Res   (United States)

Author keywords

Apoptosis; Bax; Death receptors; p53; Transcription; Tumours

Indexed keywords

PROTEIN P53; TRANSCRIPTION FACTOR E2F;

APOPTOSIS; CELL CYCLE; CELL TYPE; CONTROLLED STUDY; HUMAN; REVIEW; TRANSACTIVATION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ANTIGENS, CD95; APOPTOSIS; CARRIER PROTEINS; CASPASES; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; MITOCHONDRIA; MODELS, GENETIC; RECEPTORS, TUMOR NECROSIS FACTOR; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032984992     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050267     Document Type: Review

References (104)

1. 1 Crook T., Marston N. J., Sara E. A. and Vousden K. H. (1994) Transcriptional activation by p53 correlates with suppression of growth but not transformation. Cell 79: 817-827
2. 2 Pietenpol J. A., Tokino T., Thiagaligam S., El-Deiry W., Kinzler K. W. and Vogelstein B. (1994) Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc. Natl. Acad. Sci. USA 91: 1998-2002
3. 3 Symonds H., Krall L., Remington L., Saenzrobles M., Lowe S., Jacks T. et al (1994) p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78: 703-711
4. 4 Martin S. and Green D. (1995) Protease activation during apoptosis: death by a thousand cuts? Cell 82: 349-352
5. 5 Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A. and Nagata S. (1998) A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391: 43-50
6. 6 Clarke A. R., Purdie C. A., Harrison D. J., Morris R. G., Bird C. C., Hooper M. L. et al. (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362: 849-852
7. 7 Lowe S. W., Schmitt E. M., Smith S. W., Osborne B. A. and Jacks T. (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849
8. 8 Shaw P., Bovey R., Tardy S., Sahli R., Sordat R. and Costa J. (1992) Induction of apoptosis by wild type p53 in a human colon tumor-derived cell line. Proc. Natl. Acad. Sci. USA 89: 4495-4499
9. 9 Yonish-Rouach E., Borde J., Gotteland M., Mishal Z., Viron A. and May E. (1994) Induction of apoptosis by transiently transfected metabolically stable wt p53 in transformed cell lines. Cell Growth Differ. 1: 39-47
10. 10 Wu X. W. and Levine A. J. (1994) p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA 91: 3602-3606
11. 11 Hermeking H. and Eick D. (1994) Mediation of c-myc-induced apoptosis by p53. Science 265: 2091-2092
12. 12 Cai Z., Capoulade C., Moyret-Lalle C., Amor-Gueret M., Feunteun J., Larsen A. K. et al. (1997) Resistance of MCF-7 human breast carcinoma cells to TNF-induced cell death is associated with loss of p53 function. Oncogene 15: 2817-2826
13. 13 Klefstrom J., Arighi E., Littlewood T., Jäättela M., Saksela E., Evan G. I. et al. (1997) Induction of TNF-sensitive cellular phenotype by c-Myc involves p53 and impaired NF-kB activation. EMBO J. 16: 7382-7392
14. 14 Levine A. J. (1997) p53, the cellular gatekeeper for growth and division. Cell 88: 323-331
15. 15 Harris C. (1996) Structure and function of the p53 tumour suppressor: clues for rational cancer therapeutic stratagies. J. Natl. Cancer Inst. 88: 1442-1455
16. 16 El-Deiry W., Tokino T., Velculescu V. E., Levy D. B., Parson V. E., Trent J. M. et al. (1993) WAF1, a potential mediator of p53 tumour suppression. Cell 75: 817-825
17. 17 Harper J. W., Adami G. R., Wei N., Keyomarsi K. and Elledge S. J. (1993) The p21 CDK-interacting protein cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816
18. 18 Gu Y., Turck C. W. and Morgan D. O. (1993) Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366: 707-710
19. 19 Zhang H., Hannon G. J. and Beach D. (1994) p21-containing cyclin kinases exist in both active and inactive states. Genes Dev. 8: 1750-1758
20. CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675-684
21. 21 Brugarolas J., Chandrasekaran C., Gordon J. I., Beach D., Jacks T. and Hannon G. J. (1995) Radiation-induced cell-cycle arrest compromised by p21 deficiency. Nature 377: 552-556
22. 22 Polyak K., Waldman T., He T.-C., Kinzler K. W. and Vogelstein B. (1996) Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev. 10: 1945-1952
23. 23 Waldman T., Kinzler K. W. and Vogelstein B. (1995) p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 55: 5187-5190
24. CIP1/WAF1 gene in normal diploid human fibroblasts. Science 277: 831-834
25. 25 Kroemer G., Zamzami N. and Susin S. A. (1997) Mitochondrial control of apoptosis. Immunol Today 18: 45-51
26. 26 Liu X., Kim C., Yang J., Jemmerson R. and Wang X. (1996) Induction of apoptotic programme in cell-free extracts: requirement for dATP and cytochrome c. Cell 86: 147-157
27. 27 Yang J., Liu X., Bhalla K., Kim C. N., Ibrado A. M., Cai J. et al. (1997) Prevention of apoptosis by bcl-2: release of cytochrome c from mitochondria blocked. Science 275: 1129-1132
28. 28 Kluck R. M., Bossy-Wetzel E., Green D. R. and Newmeyer D. D. (1997) The release of cytochrome c from mitochondria: a primary site for bcl-2 regulation of apoptosis. Science 275: 1132-1136
29. L regulates the membrane potential and volume homeostasis of mitochondria. Cell 91: 627-637
30. 30 Reed J. C. (1997) Double identity for proteins of the Bcl-2 family. Nature 387: 773-776
31. L, an inhibitor of programmed cell death. Nature 381: 335-341
32. 32 Minn A., Velez P., Schendel S., Liang H., Muchmore S., Fesik S. et al. (1997) Bcl-x(L) forms an ion channel in synthetic lipid membranes. Nature 385: 353-357
33. 33 Schendel S., Xie Z., Montal M., Matsuyama S., Montal M. and Reed J. (1997) Channel formation by antiapoptotic protein Bcl-2. Proc. Natl. Acad. Sci. USA 94: 5113-5118
34. 34 Miyashita T. and Reed J. C. (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299
35. 35 Knudson M. C., Tung K. S. K., Tourtellotte W. G., Brown G. A. J. and Korsmeyer S. J. (1995) Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270: 96-98
36. 36 McCurrach M. E., Connor T. M. F., Knudson M. C., Korsmeyer S. J. and Lowe S. W. (1997) bax deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc. Natl. Acad. Sci. USA 94: 2345-2349
37. 37 Yin C., Knudson C. M., Korsmeyer S. J. and Van Dyke T. (1997) Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 385: 637-640
38. 38 Lotem J., Peled-Kamar M., Groner Y. and Sachs L. (1996) Cellular oxidative stress and the control of apoptosis by wild-type p53, cytotoxic compounds, and cytokines. Proc. Natl. Acad. Sci. USA 93: 9166-9171
39. 39 Johnson T. M., Yu Z., Ferrans V. J., Lowenstein R. A. and Finkel T. (1996) Reactive oxygen species are downstream mediators of p53-dependent apoptosis. Proc. Natl. Acad. Sci. USA 93: 11848-11852
40. 40 Polyak K., Xia Y., Zweier J. L., Kinzler, K. W. and Vogelstein B. (1997) A model for p53-induced apoptosis. Nature 389: 300-305
41. 41 Nagata S. (1997) Apoptosis by death factor. Cell 88: 355-365
42. 42 Owen-Schaub L. B., Zhang W., Cusack J. C., Angelo L. S. Santee S. M., Fujiwara T. et al. (1995) Wild-type human p53 and a temperature sensitive mutant induce Fas APO-1 expression. Mol. Cell Biol. 15: 3032-3040
43. 43 Reinke V. and Lozano G. (1997) The p53 targets mdm2 and Fas are not required as mediators of apoptosis in vivo. Oncogene 15: 1527-1534
44. 44 Reap E. A., Roof K., Maynor K., Borrero M., Booker J. and Cohen P. L. (1997) Radiation and stress-induced apoptosis: a role for Fas/Fas ligand interactions. Proc. Natl. Acad. Sci. USA 94: 5750-5755
45. 45 Strasser A., Harris A. W., Huang D. C. S., Krammer P. H. and Cory S. (1995) Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14: 6136-6147
46. 46 Itoh N., Tsujimoto Y. and Nagata S. (1993) Effects of bcl-2 on Fas antigen-mediated cell death. J. Immunol. 151: 621-627
47. 47 Hueber A.-O., Zörnig M., Lyon D., Suda T., Nagata S. and Evan G. I. (1997) Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis. Science 278: 1305-1309
48. 48 Wu G. S., Burns T. F., McDonald E. R., Jiang W., Meng R., Krantz I. D. et al. (1997) KILLER DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nature Genet. 17: 141-143
49. 49 Harrington E. A., Bennett M. R., Fanidi A. and Evan G. I. (1994) c-myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J. 13: 3286-3295
50. 50 Yonish-Rouach E., Resnitzky D., Lotem J., Sachs L., Kimchi A. and Oren M. (1991) Wild-type p53 induces apoptosis of mycloid leukaemic cells that is inhibited by interleukin-6. Nature 353: 345-347
51. 51 Canman C. E., Gilmer T. M., Coutts S. B. and Kastan M. B. (1995) Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev. 9: 600-611
52. 52 Lin Y. and Benchimol S. (1995) Cytokines inhibit p53-mediated apoptosis but not p53-mediated G1 arrest. Mol. Cell. Biol. 15: 6045-6054
53. 53 Kauffmann-Zeh A., Rodriguez-Viciana P., Ulrich E., Gilbert C., Coffer P., Downward J. et al. (1997) Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 385: 544-548
54. 54 Shaulian E., Resnitzky D., Shifmen O., Blandino G., Amsterdam A., Yayon A. et al. (1997) Induction of Mdm2 and enhancement of cell survival by bFGF. Oncogene 15: 2717-2725
55. 55 Buckbinder L., Talbolt R., Velasco-Miguel S., Takenaka L, Faha B., Seizinger B. R. et al. (1995) Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377: 646-649
56. 56 Rajah R., Valentinis B. and Cohen P. (1997) Insulin-like growth factor (IGF)-binding protein-3 induced apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53-and IGF-independent mechanism. J. Biol. Chem. 272: 12181-12188
57. 57 Israeli D., Tessler E., Haupt Y., Elkeles A., Wilder S., Amson R. et al. (1997) A novel p53-inducible gene, PAG608, encodes a nuclear zinc finger protein whose expression promotes apoptosis. EMBO J. 16: 4384-4392
58. L depends on normal p53 function. Oncogene 13: 2287-2293
59. 59 Merchant A. K., Loney T. L. and Maybaum J. (1996) Expression of wild-type p53 stimulates an increase in both Bax and Bcl-XL protein content in HT29 cells. Oncogene 13: 2631-2637
60. 60 Zhan Q., Bieszczad C., Bae I., Fornace A. J. and Craig R. (1997) Induction of the BCL2 family member MCL1 as an early response to DNA damage. Oncogene 14: 1031-1039
61. 61 Ko L. J. and Prives C. (1996) p53: puzzle and paradigm. Genes Dev. 10: 1054-1072
62. 62 Murphy M., Hinman A. and Levine A. J. (1996) Wild-type p53 negatively regulates the expression of a microtubule-associated protein. Genes Dev. 10: 2971-2980
63. 63 Miyashita T., Harigai M., Hanaka M. and Reed J. C. (1994) Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res. 54: 3131-3135
64. 64 Sabbatini P., Chiou S.-K., Rao L. and White E. (1995) Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19K protein. Mol. Cell. Biol. 15: 1060-1070
65. 65 Caelles C., Helmberg A. and Karin M. (1994) p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 370: 220-223
66. 66 Wagner A. J., Kokontis J. M. and Hay N. (1994) Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell-cycle arrest and the ability of p53 to induce p21waf1/cip1. Genes Dev. 8: 2817-2830
67. 67 Yonish-Rouach E., Deguin V., Zaitchouk T., Breugnot C., Mishal Z., Jankins J. R. et al. (1995) Transcriptional activation plays a role in the induction of apoptosis by transiently transfected wild-type p53. Oncogene 11: 2197-2205
68. 68 Attardi L. D., Lowe S. W., Brugarolas J. and Jacks T. (1996) Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis. EMBO J. 15: 3639-3701
69. 69 Sabbatini P., Lin J., Levine A. J. and White E. (1995) Essential role for p53-mediated transcription in E1A-induced apoptosis. Genes Dev. 9: 2184-2192
70. 70 Chen X., Ko L. J., Jayaraman L. and Prives C. (1996) p53 levels, functional domains and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev. 10: 2438-2451
71. 71 Wang X. W., Vermeulen W., Coursen J. D., Gibson M., Lupold S. E., Forrester K. et al. (1996) The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway. Genes Dev. 10: 1219-1232
72. 72 Haupt Y., Rowan S., Shaulian E., Vousden K. H. and Oren M. (1995) Induction of apoptosis in HeLa cells by trans-activation deficient p53. Genes Dev. 9: 2170-2183
73. 73 Walker K. K. and Levine A. J. (1996) Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc. Natl. Acad. Sci. USA 93: 15335-15340
74. 74 Sakamuro D., Sabbatini P., White E. and Prendergast G. C. (1997) The polyproline region of p53 is required to activate apoptosis but not growth arrest. Oncogene 15: 887-898
75. 75 Ruaro E. M., Collavin L., Del Sal G., Haffner R., Oren M., Levine A. J. et al. (1997) A proline-rich motif in p53 is required for transactivation independent growth arrest as induced by Gasl. Proc. Natl. Acad. Sci. USA 94: 4675-4680
76. 76 Friedlander P., Haupt Y., Prives C. and Oren M. (1996) A mutant p53 that discriminated between p53 responsive genes cannot induce apoptosis. Mol. Cell. Biol. 16: 4961-4971
77. 77 Ludwig R. L., Bates S. and Vousden K. H. (1996) Differential transcriptional activation of target cellular promoters by p53 mutants with impaired apoptotic function. Mol. Cell. Biol. 16: 4952-4960
78. 78 Wang Y. and Prives C. (1995) Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases. Nature 376: 88-91
79. 79 Barlow C., Brown K. D., Deng C.-X., Tagle D. A. and Wynshaw-Boris A. (1997) Atm selectively regulates distinct p53-dependent cell-cycle checkpoint and apoptotic pathways. Nature Genet. 17: 453-455
80. 80 Guillouf C., Grana X., Selvakumaran M., De Luca A., Giordano A., Hoffman B. et al. (1995) Dissection of the genetic programmes of p53-mediated G1 growth arrest and apoptosis: blocking p53-induced apoptosis unmasks G1 arrest. Blood 85: 2691-2698
81. 81 Chiou S. K., Rao L. and White E. (1994) Bcl-2 blocks p53-dependent apoptosis. Mol. Cell. Biol. 14: 2556-2563
82. 82 Di Leonardo A., Linke S. P., Clarkin K. and Wahl G. M. (1994) DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev. 8: 2540-2551
83. 83 Lowe S. W. and Ruley H. E. (1993) Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev. 7: 535-545
84. 84 Waldman T., Zhang Y., Dillehay L., Yu J., Kinzler K., Vogelstein B. et al. (1997) Cell-cycle arrest versus cell death in cancer therapy. Nature Med. 3: 1034-1036
85. 85 Hall M. and Peters G. (1996) Genetic alterations of cyclins, cyclin-dependent kinases and edk inhibitors in human cancers. Adv. Cancer Res. 68: 67-108
86. 86 Field S. J., Tsai F.-Y., Kuo F., Zubiaga A. M., Kaelin W. G., Livingston D. M. et al. (1996) E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85: 549-561
87. 87 Yamasaki L., Jacks T., Bronson R., Goillot, E., Harlow E. and Dyson N. (1996) Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85: 537-548
88. 88 Phillips A. C., Bates S., Ryan K. M., Helin K. and Vousden K. H. (1997) Induction of DNA synthesis and apoptosis are separable functions of E2F-1. Genes Dev. 11: 1853-1863
89. 89 Qin X.-Q., Livingston D. M., Kaelin W. G. and Adams P. D. (1994) Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA 91: 10918-10922
90. 90 Morgenbesser S. D., Williams B. O., Jacks T. and DePinho R. A. (1994) p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 371: 72-74
91. 91 Hupp T. R., Meek D. W., Midgley C. A. and Lane D. P. (1993) Activation of the cryptic DNA binding function of mutant forms of p53. Nucleic Acids Res. 21: 3167-3174
92. 92 Hupp T. R. and Lane D. P. (1994) Regulation of the cryptic sequence-specific DNA-binding function of p53 by protein kinases. CSH Symp. Quant. Biol. 59: 195-206
93. 93 Hupp T. R., Sparks A. and Lane D. P. (1995) Small peptides activate the latent sequence-specific DNA binding function of p53. Cell 83: 237-245
94. 94 Halazonetis T. D. and Kandil A. N. (1993) Conformational shifts propagate from the oligomerization domain of p53 to its tetrameric DNA binding domain and restore DNA binding to select p53 mutants. EMBO J. 12: 5057-5064
95. 95 Selivanova G., Iotsova V., Okan I., Pritsche M., Ström M., Groner B. et al. (1997) Restoration of the growth suppression function of mutant p53 by a synthetic peptide derived from the p53 C-terminal domain. Nature Med. 3: 632-638
96. 96 Abarzúa P., LoSardo J. E., Gubler M. L., Spathis R., Lu Y.-A., Felix A. et al. (1996) Restoration of the transcription activation function to mutant p53 in human cancer cells. Oncogene 13: 2477-2482
97. 97 Abarzúa P., LoSardo J. E., Gubler M. L. and Neri A. (1995) Microinjection of monoclonal antibody PAb421 into human SW480 colorectal carcinoma cells restores the transcriptional activation function to mutant p53. Cancer Res. 55: 3490-3494
98. 98 Pan H. C. and Griep A. E. (1994) Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. Genes Dev. 8: 1285-1299
99. 99 Howes K. A., Ransom L. N., Papermaster D. S., Lasudry J. G. H., Albert D. M. and Windle J. J. (1994) Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. Genes Dev. 8: 1300-1310
100. 100 Demers G. W., Foster S. A., Halbert C. L. and Galloway D. A. (1994) Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7. Proc. Natl. Acad. Sci. USA 91: 4382-4386
101. 101 Slebos R. J. C., Lee M. H., Plunkett B. S., Kessis T. D., Williams B. O., Jacks T. et al. (1994) p53-dependent G(1) arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc. Natl. Acad. Sci. USA 91: 5320-5324
102. 102 Hickman E. S., Bates S. and Vousden K. H. (1997) Perturbation of the p53 response by human papillomavirus type 16 E7. J. Virol. 71: 3710-3718
103. 103 Bottger A., Bottger V., Sparks A., Liu W., Howard S. and Lane D. (1997) Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo. Curr. Biol. 7: 860-869
104. 104 Rampino N., Yamamoto H., Ionov Y., Li Y., Sawai H., Reed J. et al. (1997) Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 275: 967-969